REG-Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer
Lakefront Biotherapeutics appointed Eric Hedrick, MD, as its new Chief Medical Officer, effective immediately. Hedrick brings a 25-year track record in biotech, including prior CMO roles at Epizyme and BeiGene, and will lead the clinical development of the newly acquired Ouro Medicines portfolio.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.